Melagatran
Alternative Names: Exanta; H 319/68Latest Information Update: 05 Nov 2023
At a glance
- Originator AstraZeneca
- Class Antithrombotics; Azetidines; Benzylamines; Small molecules
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Deep vein thrombosis; Thromboembolism
- Discontinued Coronary thrombosis; Shock; Thrombosis
Most Recent Events
- 14 Feb 2006 Discontinued - Phase-III for Deep vein thrombosis in USA (SC)
- 14 Feb 2006 Discontinued - Phase-III for Thromboembolism in USA (SC)
- 14 Feb 2006 Discontinued - Preclinical for Coronary thrombosis in Sweden (unspecified route)